Advanced search
Publication Cover
Nanomedicine Volume 9, 2014 - Issue 16
Submit an article Journal homepage
349
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Development of Stabilized Glucomannosylated Chitosan Nanoparticles Using Tandem Crosslinking Method for Oral Vaccine Delivery

Harshad Harde1 Center for Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education & Research, SAS Nagar, Punjab, 160062, India.View further author information
,
Ashish Kumar Agrawal1 Center for Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education & Research, SAS Nagar, Punjab, 160062, India.View further author information
&
Sanyog Jain1 Center for Pharmaceutical Nanotechnology, Department of Pharmaceutics, National Institute of Pharmaceutical Education & Research, SAS Nagar, Punjab, 160062, India.Correspondence[email protected]
View further author information
Pages 2511-2529 | Received 08 Aug 2013, Accepted 15 Dec 2013, Published online: 05 Mar 2014

References

  • Pan Y , LiY, ZhaoHet al. Bioadhesive polysaccharide in protein delivery system: chitosan nanoparticles improve the intestinal absorption of insulin in vivo. Int. J. Pharm. 249 (1–2), 139–147 (2002).
  • Xu Y , DuY. Effect of molecular structure of chitosan on protein delivery properties of chitosan nanoparticles. Int. J. Pharm.250(1), 215–226 (2003).
  • Calvo P , Remuñán López C, Vila Jato JL, Alonso MJ. Novel hydrophilic chitosan polyethylene oxide nanoparticles as protein carriers. J. Appl. Polym. Sci.63(1), 125–132 (1997).
  • Csaba N , Koping-HoggardM, AlonsoMJ. Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery. Int. J. Pharm.382(1–2), 205–214 (2009).
  • Katas H , AlparHO. Development and characterisation of chitosan nanoparticles for siRNA delivery. J. Control. Release115(2), 216–225 (2006).
  • Bowman K , LeongKW. Chitosan nanoparticles for oral drug and gene delivery. Int. J. Nanomed.1(2), 117–128 (2006).
  • Lopez Leon T , CarvalhoELS, SeijoB, Ortega Vinuesa JL, Bastos Gonzalez D. Physicochemical characterization of chitosan nanoparticles: electrokinetic and stability behavior. J. Colloid. Interf. Sci.283(2), 344–351 (2005).
  • Sung H-W , Sonaje K, Liao Z-X, Hsu L-W, Chuang E-Y. pH-responsive nanoparticles shelled with chitosan for oral delivery of insulin: from mechanism to therapeutic applications. Acc. Chem. Res.45(4), 619–629 (2012).
  • Sonaje K , Chen Y-J, Chen H-L et al. Enteric-coated capsules filled with freeze-dried chitosan/poly (γ-glutamic acid) nanoparticles for oral insulin delivery. Biomaterials31(12), 3384–3394 (2010).
  • Makhlof A , TozukaY, TakeuchiH. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Eur. J. Pharm. Sci.42(5), 445–451 (2011).
  • Sarmento B , RibeiroA, VeigaF, SampaioP, NeufeldR, FerreiraD. Alginate/chitosan nanoparticles are effective for oral insulin delivery. Pharm. Res.24(12), 2198–2206 (2007).
  • Tiwari S , AgrawalGP, VyasSP. Molecular basis of the mucosal immune system: from fundamental concepts to advances in liposome-based vaccines. Nanomedicine5(10), 1617–1640 (2010).
  • Fahmy TM , DementoSL, CaplanMJ, MellmanI, SaltzmanWM. Design opportunities for actively targeted nanoparticle vaccines. Nanomedicine3(3), 343–355 (2008).
  • Keler T , RamakrishnaV, FangerMW. Mannose receptor-targeted vaccines. Exp. Opin. Biol. Ther.4(12), 1953–1962 (2004).
  • Sheng KC , KalkanidisM, PouniotisDSet al. Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo. Eur. J. Immunol. 38(2), 424–436 (2008).
  • Jain S , HardeH, IndulkarA, AgrawalAK. Improved stability and immunological potential of tetanus toxoid containing surface engineered bilosomes following oral administration. Nanomedicine10(2), 431–440 (2014).
  • Jain S , IndulkarA, HardeH, AgrawalAK. Oral mucosal immunization using glucomannosylated bilosomes. J. Biomed. Nanotechnol.10(6), 932–947 (2014).
  • Du J , SunR, ZhangSet al. Novel polyelectrolyte carboxymethyl konjac glucomannan-chitosan nanoparticles for drug delivery. Macromol. Rapid Comm. 25(9), 954–958 (2004).
  • Du J , SunR, ZhangS, ZhangLF, XiongCD, PengYX. Novel polyelectrolyte carboxymethyl konjac glucomannan-chitosan nanoparticles for drug delivery. I. Physicochemical characterization of the carboxymethyl konjac glucomannan-chitosan nanoparticles. Biopolymers78(1), 1–8 (2005).
  • Fernandez-Urrusuno R , CalvoP, Remunan-LopezC, Vila-JatoJL, AlonsoMJ. Enhancement of nasal absorption of insulin using chitosan nanoparticles. Pharm. Res.16(10), 1576–1581 (1999).
  • Ma Z , YeohHH, LimLY. Formulation pH modulates the interaction of insulin with chitosan nanoparticles. J. Pharm. Sci.91(6), 1396–1404 (2002).
  • Boratynski J , ZalT. Colorimetric micromethods for glutaraldehyde determination by means of phenol and sulfuric acid or phenol and perchloric acid. Anal. Biochem.184(2), 259–262 (1990).
  • Lyman GW , JohnsonRN, KhoB. Gas chromatographic determination of glutaraldehyde. J. Chromatogr. A.156(2), 285–291 (1978).
  • Jain AK , SwarnakarNK, GoduguC, SinghRP, JainS. The effect of the oral administration of polymeric nanoparticles on the efficacy and toxicity of tamoxifen. Biomaterials32(2), 503–515 (2011).
  • Jain S , RathiVV, JainAK, DasM, GoduguC. Folate-decorated PLGA nanoparticles as a rationally designed vehicle for the oral delivery of insulin. Nanomedicine7(9), 1311–1337 (2012).
  • Xie SY , WangSL, ZhaoBK, HanC, WangM, ZhouWZ. Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles. Colloids Surf. B.67(2), 199–204 (2008).
  • Amidi M , RomeijnSG, BorchardG, JungingerHE, HenninkWE, JiskootW. Preparation and characterization of protein-loaded N-trimethyl chitosan nanoparticles as nasal delivery system. J. Control. Release111(1–2), 107–116 (2006).
  • Sayin B , SomavarapuS, LiXWet al. Mono-N-carboxymethyl chitosan (MCC) and N-trimethyl chitosan (TMC) nanoparticles for non-invasive vaccine delivery. Int. J. Pharm. 363 (1–2), 139–148 (2008).
  • Jelvehgari M , Zakeri-MilaniP, Siahi-ShadbadMRet al. Development of pH-sensitive insulin nanoparticles using eudragit L100–55 and chitosan with different molecular weights. AAPS PharmSciTech. 11(3), 1237–1242 (2010).
  • Zhang N , LiJ, JiangW, RenC, XinJ, LiK. Effective protection and controlled release of insulin by cationic beta-cyclodextrin polymers from alginate/chitosan nanoparticles. Int. J. Pharm.393(1–2), 213–219 (2010).
  • Shukla A , KatareOP, SinghB, VyasSP. M-cell targeted delivery of recombinant hepatitis B surface antigen using cholera toxin B subunit conjugated bilosomes. Int. J. Pharm.385(1–2), 47–52 (2010).
  • Roger E , LagarceF, BenoitJP. The gastrointestinal stability of lipid nanocapsules. Int. J. Pharm.379(2), 260–265 (2009).
  • Kalaria DR , SharmaG, BeniwalV, Ravi Kumar MNV. Design of biodegradable nanoparticles for oral delivery of doxorubicin: in vivo pharmacokinetics and toxicity studies in rats. Pharm. Res.26(3), 492–501 (2009).
  • Wiecinski PN , MetzKM, ManghamAN, JacobsonKH, HarriersRJ, PedersenJA. Gastrointestinal biodurability of engineered nanoparticles: development of an in vitro assay. Nanotoxicology3(3), 202–214 (2009).
  • Shan X , LiuC, YuanYet al.: In vitro macrophage uptake and in vivo biodistribution of long-circulation nanoparticles with poly(ethylene-glycol)-modified PLA (BAB type) triblock copolymer. Colloids Surf. B.72(2), 303–311 (2009).
  • Sarti F , PereraG, HintzenFet al.: In vivo evidence of oral vaccination with PLGA nanoparticles containing the immunostimulant monophosphoryl lipid A. Biomaterials32(16), 4052–4057 (2011).
  • Garinot M , FievezV, PourcelleVet al. PEGylated PLGA-based nanoparticles targeting M cells for oral vaccination. J. Control. Release 120(3), 195–204 (2007).
  • Jain S , SinghP, MishraV, VyasS. Mannosylated niosomes as adjuvant–carrier system for oral genetic immunization against hepatitis B. Immunol. Lett.101(1), 41–49 (2005).
  • Jain S , SharmaRK, VyasSP. Chitosan nanoparticles encapsulated vesicular systems for oral immunization: preparation, in vitro and in vivo characterization. J. Pharm. Pharmacol.58(3), 303–310 (2006).
  • Vila A , SanchezA, JanesKet al. Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice. Eur. J. Pharm. Biopharm. 57(1), 123–131 (2004).
  • Zhu Y , LiX, ChenCet al. Effects of aluminum trichloride on the trace elements and cytokines in the spleen of rats. Food Chem. Toxicol. 50(8), 2911–2915 (2012).
  • Rahman Z , ZidanAS, KhanMA. Non-destructive methods of characterization of risperidone solid lipid nanoparticles. Eur. J. Pharm. Biopharm.76(1), 127–137 (2010).
  • Jain S , KumarD, SwarnakarNK, ThankiK. Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel. Biomaterials33(28), 6758–6768 (2012).
  • Kreuter J . Peroral administration of nanoparticles. Adv. Drug Del. Rev.7(1), 71–86 (1991).
  • Harde H , DasM, JainS. Solid lipid nanoparticles: an oral bioavailability enhancer vehicle. Exp. Opin. Drug Del.8(11), 1–18 (2011).
  • Gan Q , WangT, CochraneC, MccarronP. Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery. Colloids Surf. B.44(2–3), 65–73 (2005).
  • Ying G-Q , Xiong W-Y, Wang H, Sun Y, Liu H-Z. Preparation, water solubility and antioxidant activity of branched-chain chitosan derivatives. Carbohyd. Polym.83(4), 1787–1796 (2011).
  • Abdelwahed W , DegobertG, StainmesseS, FessiH. Freeze-drying of nanoparticles: Formulation, process and storage considerations. Adv. Drug Del. Rev.58(15), 1688–1713 (2006).
  • Van De Weert M , HenninkWE, JiskootW. Protein instability in poly (lactic-co-glycolic acid) microparticles. Pharm. Res.17(10), 1159–1167 (2000).
  • Hopkins S , NiedergangF, Corthesy-TheulazI, KraehenbuhlJ. A recombinant Salmonella typhimurium vaccine strain is taken up and survives within murine Peyer‘s patch dendritic cells. Cell Microbiol.2(1), 59–68 (2000).
  • Tacken PJ , De Vries IJM, Torensma R, Figdor CG. Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting. Nat. Rev. Immunol.7(10), 790–802 (2007).
  • Mcclean S , ProsserE, MeehanEet al. Binding and uptake of biodegradable poly-dl-lactide micro-and nanoparticles in intestinal epithelia. Eur. J. Pharm. Sci. 6(2), 153–163 (1998).
  • Mathiowitz E , JacobJS, JongYSet al. Biologically erodable microspheres as potential oral drug delivery systems. Nature 386(6623), 410–414 (1997).
  • Artursson P , LindmarkT, DavisSS, IllumL. Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm. Res.11(9), 1358–1361 (1994).
  • Dodane V , Amin Khan M, Merwin JR. Effect of chitosan on epithelial permeability and structure. Int. J. Pharm.182(1), 21–32 (1999).
  • Rieux AD , PourcelleV, CaniPD, Marchand-BrynaertJ, PréatV. Targeted nanoparticles with novel non-peptidic ligands for oral delivery. Adv. Drug Del. Rev.65(6), 833–844 (2013).
  • Des Rieux A , FievezV, GarinotM, SchneiderYJ, PréatV. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J. Control. Release116(1), 1–27 (2006).
  • Luo Z , LiP, DengJet al. Cationic polypeptide micelle-based antigen delivery system: a simple and robust adjuvant to improve vaccine efficacy. J. Control. Release 170(2), 259–267 (2013).
  • Mackay IR , RosenFS, AdaG. Vaccines and vaccination. N. Engl. J. Med.345(14), 1042–1053 (2001).
  • Leleux J , RoyK. Micro and nanoparticle-based delivery systems for vaccine immunotherapy: an immunological and materials perspective. Adv. Healthc. Mater.2(1), 72–94 (2013).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.